Pub Date : 2026-06-01Epub Date: 2026-01-04DOI: 10.1016/j.biomaterials.2026.123986
Biaobiao Wang , Jiahui Cao , Jingqiao Wu , Yiwen Zhao , Yao Zhang , Frank Abendroth , Caorui Lin , Li Zhong , Huanan Yu , Yiqi Seow , Meitong Ou , Olalla Vázquez , Lin Mei , HaiFang Yin , Gang Han
Although peptide-based delivery strategies show promise for muscle and heart diseases, delivery of biotherapeutics to both skeletal and cardiac muscles remains challenging. Here, we identified a muscle-homing peptide (BV2) against blood vessel epicardial substance (BVES) by phage display. BV2 shows high binding affinity to BVES and is internalized primarily via caveolae-mediated endocytosis. Importantly, BV2 enables efficient delivery of Duchenne Muscular Dystrophy (DMD) phosphorodiamidate morpholino oligomer (PMO), mCherry protein and exosomes to skeletal muscle and heart in vivo. BV2-mCherry protein and BV2-E31R anti-myostatin peptide were effectively delivered to muscle layers when microneedles loaded with these biotherapeutics were implanted on hindlimbs of mice. Muscle mass and myofiber size also significantly increased in muscle atrophy mice grafted with BV2-E31R microneedles. Moreover, significantly enhanced restoration of dystrophin protein was achieved in peripheral and cardiac muscles of dystrophin-deficient mdx and dystrophin/utrophin double-knockout mice when exosomes simultaneously modified with BV2 and PMO. These findings highlight the potency of BV2 in directing targeted delivery of diverse biotherapeutics to muscle and heart, thus providing an effective tool for DMD and other muscular and cardiac disorders.
{"title":"Cardiac and skeletal muscle delivery of biotherapeutics with a blood vessel epicardial substance-targeting peptide","authors":"Biaobiao Wang , Jiahui Cao , Jingqiao Wu , Yiwen Zhao , Yao Zhang , Frank Abendroth , Caorui Lin , Li Zhong , Huanan Yu , Yiqi Seow , Meitong Ou , Olalla Vázquez , Lin Mei , HaiFang Yin , Gang Han","doi":"10.1016/j.biomaterials.2026.123986","DOIUrl":"10.1016/j.biomaterials.2026.123986","url":null,"abstract":"<div><div>Although peptide-based delivery strategies show promise for muscle and heart diseases, delivery of biotherapeutics to both skeletal and cardiac muscles remains challenging. Here, we identified a muscle-homing peptide (BV2) against blood vessel epicardial substance (BVES) by phage display. BV2 shows high binding affinity to BVES and is internalized primarily via caveolae-mediated endocytosis. Importantly, BV2 enables efficient delivery of Duchenne Muscular Dystrophy (DMD) phosphorodiamidate morpholino oligomer (PMO), mCherry protein and exosomes to skeletal muscle and heart <em>in vivo</em>. BV2-mCherry protein and BV2-E31R anti-myostatin peptide were effectively delivered to muscle layers when microneedles loaded with these biotherapeutics were implanted on hindlimbs of mice. Muscle mass and myofiber size also significantly increased in muscle atrophy mice grafted with BV2-E31R microneedles. Moreover, significantly enhanced restoration of dystrophin protein was achieved in peripheral and cardiac muscles of dystrophin-deficient <em>mdx</em> and dystrophin/utrophin double-knockout mice when exosomes simultaneously modified with BV2 and PMO. These findings highlight the potency of BV2 in directing targeted delivery of diverse biotherapeutics to muscle and heart, thus providing an effective tool for DMD and other muscular and cardiac disorders.</div></div>","PeriodicalId":254,"journal":{"name":"Biomaterials","volume":"329 ","pages":"Article 123986"},"PeriodicalIF":12.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145922389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-06-01Epub Date: 2026-01-03DOI: 10.1016/j.biomaterials.2026.123983
Rongguo Yu , Jiamei Xiao , Zhencheng Xiong , Xiaoyang Wu , Chaoyi Zhang , Yusheng Zhang , Kangkang Huang , Jing Sun , Hongsong Fan , Hao Liu
Cervical nerve root injury (CNRI) presents significant clinical challenges owing to complex anatomical constraints and poor intrinsic regenerative capacity. In this study, we introduce an in situ-sprayable magnetoelectric hydrogel (DG/FBD) engineered through dynamic covalent assembly and photo-triggered stabilization. The construction of critical boronate ester bonding between dopamine-modified Fe3O4@BaTiO3 nanoparticles and phenylboronic acid-functionalized dextran endows DG/FBD with optimal viscosity (87 mPa s), rapid gelation (<2s) and robust tissue adhesion (22.11 kPa), allowing for precise deposition along tortuous nerve roots while conforming to branched cervical anatomy. We then establish a wireless magnetic actuation platform with conductivity modulation enabled spatiotemporally controllable bioelectronic interfacing. In CNRI models loading with magnetic stimulation, we found the hydrogel spray significantly promotes axonal regeneration and myelination, and importantly, improving functional recovery, including enhanced pain and temperature sensation, as well as increased grip strength. We also demonstrate accelerated neural differentiation of BMSCs and attenuated astrogliosis by in vitro studies. Mechanistically, we reveal that magnetoelectrically triggered CXCL12 upregulation drives Schwann cells remodeling through PI3K/AKT/mTOR inhibition and enhances autophagic flux, establishing a bioelectronic-metabolic bridge where the CXCL12-autophagy axis emerges as a fundamental regulatory node for neural regeneration. Collectively, our work pioneers wireless magnetoelectric regulation of chemokine-directed neural repair via an integrated sprayable hydrogel system that overcomes cervical interfacing constraints, establishing a promising platform for spatiotemporal microenvironmental reprogramming in complex neuropathies.
{"title":"Wireless magnetoelectric hydrogel spray reprograms the CXCL12-autophagy axis for spatiotemporally controlled cervical nerve root regeneration","authors":"Rongguo Yu , Jiamei Xiao , Zhencheng Xiong , Xiaoyang Wu , Chaoyi Zhang , Yusheng Zhang , Kangkang Huang , Jing Sun , Hongsong Fan , Hao Liu","doi":"10.1016/j.biomaterials.2026.123983","DOIUrl":"10.1016/j.biomaterials.2026.123983","url":null,"abstract":"<div><div>Cervical nerve root injury (CNRI) presents significant clinical challenges owing to complex anatomical constraints and poor intrinsic regenerative capacity. In this study, we introduce an <em>in situ</em>-sprayable magnetoelectric hydrogel (DG/FBD) engineered through dynamic covalent assembly and photo-triggered stabilization. The construction of critical boronate ester bonding between dopamine-modified Fe<sub>3</sub>O<sub>4</sub>@BaTiO<sub>3</sub> nanoparticles and phenylboronic acid-functionalized dextran endows DG/FBD with optimal viscosity (87 mPa s), rapid gelation (<2s) and robust tissue adhesion (22.11 kPa), allowing for precise deposition along tortuous nerve roots while conforming to branched cervical anatomy. We then establish a wireless magnetic actuation platform with conductivity modulation enabled spatiotemporally controllable bioelectronic interfacing. In CNRI models loading with magnetic stimulation, we found the hydrogel spray significantly promotes axonal regeneration and myelination, and importantly, improving functional recovery, including enhanced pain and temperature sensation, as well as increased grip strength. We also demonstrate accelerated neural differentiation of BMSCs and attenuated astrogliosis by in vitro studies. Mechanistically, we reveal that magnetoelectrically triggered CXCL12 upregulation drives Schwann cells remodeling through PI3K/AKT/mTOR inhibition and enhances autophagic flux, establishing a bioelectronic-metabolic bridge where the CXCL12-autophagy axis emerges as a fundamental regulatory node for neural regeneration. Collectively, our work pioneers wireless magnetoelectric regulation of chemokine-directed neural repair via an integrated sprayable hydrogel system that overcomes cervical interfacing constraints, establishing a promising platform for spatiotemporal microenvironmental reprogramming in complex neuropathies.</div></div>","PeriodicalId":254,"journal":{"name":"Biomaterials","volume":"329 ","pages":"Article 123983"},"PeriodicalIF":12.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145909462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-06-01Epub Date: 2025-12-29DOI: 10.1016/j.biomaterials.2025.123967
Jianing Yi , Yuanyu Tang , Yilin Chen , Liang Chen , Dongxue Geng , Luyao Liu , Jie Yu , Lianhong Zou , Jie Zeng , Minhuan Lan , Wenjie Gao , Ming Gao
Type 2 diabetes is a systemic disorder characterized by metabolic dysfunction and chronic inflammation, yet strategies that address both aspects remain limited. Here, we present kudzu root–derived carbon dots (KRCDs) as a natural nanomaterial that reprograms the gut microbiota-metabolite-immune axis to restore systemic homeostasis. KRCDs exhibit nanoscale crystallinity, abundant O/N functional groups, and strong antioxidant activity. In high-fat diet/streptozotocin-induced diabetic mice, KRCDs significantly lowered fasting glucose, improved glucose tolerance and insulin sensitivity, corrected lipid profiles, and reduced hepatic steatosis without detectable toxicity. Multi-omics analyses revealed increased microbial diversity, enrichment of beneficial genera such as Anaerostipes, and remodeling of fecal metabolites with a marked rise in indole-3-carboxaldehyde (I3A). This metabolite correlated with enhanced M2-like macrophage polarization across adipose tissue, intestine, kidney, liver, and pancreas, as confirmed by flow cytometry and immunofluorescence. Fecal microbiota transplantation from KRCDs-treated donors reproduced both the metabolic improvements and the organ-wide M2 polarization, confirming a microbiota-dependent mechanism. By establishing a gut microbiota–metabolite–macrophage polarization pathway, KRCDs act as safe, plant-based nanoplatforms that simultaneously correct metabolic and immune imbalance, offering a promising strategy for multi-target intervention in diabetes.
{"title":"Kudzu root-derived carbon dots modulate gut microbiota and metabolites for pan-organ targeted macrophage polarization in synergistic diabetes therapy","authors":"Jianing Yi , Yuanyu Tang , Yilin Chen , Liang Chen , Dongxue Geng , Luyao Liu , Jie Yu , Lianhong Zou , Jie Zeng , Minhuan Lan , Wenjie Gao , Ming Gao","doi":"10.1016/j.biomaterials.2025.123967","DOIUrl":"10.1016/j.biomaterials.2025.123967","url":null,"abstract":"<div><div>Type 2 diabetes is a systemic disorder characterized by metabolic dysfunction and chronic inflammation, yet strategies that address both aspects remain limited. Here, we present kudzu root–derived carbon dots (KRCDs) as a natural nanomaterial that reprograms the gut microbiota-metabolite-immune axis to restore systemic homeostasis. KRCDs exhibit nanoscale crystallinity, abundant O/N functional groups, and strong antioxidant activity. In high-fat diet/streptozotocin-induced diabetic mice, KRCDs significantly lowered fasting glucose, improved glucose tolerance and insulin sensitivity, corrected lipid profiles, and reduced hepatic steatosis without detectable toxicity. Multi-omics analyses revealed increased microbial diversity, enrichment of beneficial genera such as <em>Anaerostipes</em>, and remodeling of fecal metabolites with a marked rise in indole-3-carboxaldehyde (I3A). This metabolite correlated with enhanced M2-like macrophage polarization across adipose tissue, intestine, kidney, liver, and pancreas, as confirmed by flow cytometry and immunofluorescence. Fecal microbiota transplantation from KRCDs-treated donors reproduced both the metabolic improvements and the organ-wide M2 polarization, confirming a microbiota-dependent mechanism. By establishing a gut microbiota–metabolite–macrophage polarization pathway, KRCDs act as safe, plant-based nanoplatforms that simultaneously correct metabolic and immune imbalance, offering a promising strategy for multi-target intervention in diabetes.</div></div>","PeriodicalId":254,"journal":{"name":"Biomaterials","volume":"329 ","pages":"Article 123967"},"PeriodicalIF":12.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145909424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-06-01Epub Date: 2025-12-12DOI: 10.1016/j.biomaterials.2025.123914
Yunjiao Han , Maomao He , Linhao Zhang , Chaogan Liu , Yongchangk Qiao , Yinghua Li , Jiangli Fan , Wen Sun , Xiaojun Peng
Conventional photosensitizers frequently exhibit nonspecific accumulation in organs and are rapidly cleared from tumor sites, posing significant challenges to the precision and efficacy of in vivo phototherapy. This study presents a novel photosensitizer that markedly enhances tumor-specific accumulation and retention for up to 25 days, outperforming all existing photosensitizers. The photosensitizers are synthesized by incorporating two 3,5-dioxocyclohexanecarboxylic acid moieties onto the heptamethine cyanine scaffold. Notably, the photothermal conversion efficiency (58.28 %) and ROS generation of the synthesized Cy7DA are significantly enhanced in the NIR range (808 nm) compared to IR780 derivatives, through assembly-mediated intermolecular aggregation effect. The intrinsic tumor-targeted Cy7DA preferentially accumulates within the mitochondria of cancer cells, where it forms irreversible covalent interactions with overexpressed sulfonic acid proteins. This interaction resulted in ultralong tumor retention and nearly complete growth inhibition of large tumors (approximately 300 mm3) in vivo, following single-dose administration and three laser irradiation sessions. This research represents the first example of single-molecule photosensitizers for ultralong NIR fluorescence imaging of tumors, coupled with integrated photodynamic and photothermal therapy.
{"title":"Protein-anchored near-infrared heptamethine cyanine photosensitizer with ultralong retention for phototherapy of large tumors","authors":"Yunjiao Han , Maomao He , Linhao Zhang , Chaogan Liu , Yongchangk Qiao , Yinghua Li , Jiangli Fan , Wen Sun , Xiaojun Peng","doi":"10.1016/j.biomaterials.2025.123914","DOIUrl":"10.1016/j.biomaterials.2025.123914","url":null,"abstract":"<div><div>Conventional photosensitizers frequently exhibit nonspecific accumulation in organs and are rapidly cleared from tumor sites, posing significant challenges to the precision and efficacy of in vivo phototherapy. This study presents a novel photosensitizer that markedly enhances tumor-specific accumulation and retention for up to 25 days, outperforming all existing photosensitizers. The photosensitizers are synthesized by incorporating two 3,5-dioxocyclohexanecarboxylic acid moieties onto the heptamethine cyanine scaffold. Notably, the photothermal conversion efficiency (58.28 %) and ROS generation of the synthesized Cy7DA are significantly enhanced in the NIR range (808 nm) compared to IR780 derivatives, through assembly-mediated intermolecular aggregation effect. The intrinsic tumor-targeted Cy7DA preferentially accumulates within the mitochondria of cancer cells, where it forms irreversible covalent interactions with overexpressed sulfonic acid proteins. This interaction resulted in ultralong tumor retention and nearly complete growth inhibition of large tumors (approximately 300 mm<sup>3</sup>) in vivo, following single-dose administration and three laser irradiation sessions. This research represents the first example of single-molecule photosensitizers for ultralong NIR fluorescence imaging of tumors, coupled with integrated photodynamic and photothermal therapy.</div></div>","PeriodicalId":254,"journal":{"name":"Biomaterials","volume":"329 ","pages":"Article 123914"},"PeriodicalIF":12.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145760482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-06-01Epub Date: 2025-12-18DOI: 10.1016/j.biomaterials.2025.123929
Vaishnavi Dhawan , Bingchen Wu , Sharada Narayanan , Delin Shi , Yugma Patel , Xinyan Tracy Cui
Implantable microelectrode arrays (MEAs) are powerful tools for neurophysiological studies and hold tremendous potential as a key component of clinical neuroprostheses. However, their long-term efficacy is hampered by inflammatory responses to implantation. This study examines the impact of MEA substrate rigidity on neural recording quality and inflammatory tissue responses. We implanted stiff silicon-based and flexible polyimide-based MEAs with similar geometries in the deep brain region of the mouse striatum and performed weekly impedance and electrophysiological measurements over 4 weeks. The flexible MEAs demonstrated more reliable recording quality in terms of stable signal-to-noise ratio, single-unit yield, peak-to-peak amplitude, noise, and impedance, compared to the stiff probes, whose performance deteriorated over time. Endpoint histological analyses were performed to assess the glial scarring (Iba-1, GFAP), blood-brain barrier integrity (IgG), mechanosensitive ion channel expression (Piezo1), and neuronal population (NeuN and NF200) around the implant site. We found reduced microglial activation and IgG fouling within a 50-μm radius around the flexible MEAs compared to the stiff group. Additionally, a higher expression of Piezo1 was observed localized around the stiff MEA, correlating positively with increased Iba-1 and GFAP intensity. Our results show that flexible MEAs have improved device-tissue integration, indicated by lower inflammation levels and better recording stability. This research underscores the critical role of MEA substrate rigidity in influencing adverse tissue reactions, especially for deep brain regions. This understanding will improve our ability to design stable and reliable devices for chronic neural interface devices and beyond.
{"title":"A comparative study assessing neural recording quality and inflammatory tissue response between stiff and flexible microelectrode arrays","authors":"Vaishnavi Dhawan , Bingchen Wu , Sharada Narayanan , Delin Shi , Yugma Patel , Xinyan Tracy Cui","doi":"10.1016/j.biomaterials.2025.123929","DOIUrl":"10.1016/j.biomaterials.2025.123929","url":null,"abstract":"<div><div>Implantable microelectrode arrays (MEAs) are powerful tools for neurophysiological studies and hold tremendous potential as a key component of clinical neuroprostheses. However, their long-term efficacy is hampered by inflammatory responses to implantation. This study examines the impact of MEA substrate rigidity on neural recording quality and inflammatory tissue responses. We implanted stiff silicon-based and flexible polyimide-based MEAs with similar geometries in the deep brain region of the mouse striatum and performed weekly impedance and electrophysiological measurements over 4 weeks. The flexible MEAs demonstrated more reliable recording quality in terms of stable signal-to-noise ratio, single-unit yield, peak-to-peak amplitude, noise, and impedance, compared to the stiff probes, whose performance deteriorated over time. Endpoint histological analyses were performed to assess the glial scarring (Iba-1, GFAP), blood-brain barrier integrity (IgG), mechanosensitive ion channel expression (Piezo1), and neuronal population (NeuN and NF200) around the implant site. We found reduced microglial activation and IgG fouling within a 50-μm radius around the flexible MEAs compared to the stiff group. Additionally, a higher expression of Piezo1 was observed localized around the stiff MEA, correlating positively with increased Iba-1 and GFAP intensity. Our results show that flexible MEAs have improved device-tissue integration, indicated by lower inflammation levels and better recording stability. This research underscores the critical role of MEA substrate rigidity in influencing adverse tissue reactions, especially for deep brain regions. This understanding will improve our ability to design stable and reliable devices for chronic neural interface devices and beyond.</div></div>","PeriodicalId":254,"journal":{"name":"Biomaterials","volume":"329 ","pages":"Article 123929"},"PeriodicalIF":12.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145831715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-06-01Epub Date: 2025-12-12DOI: 10.1016/j.biomaterials.2025.123918
Yiwei Chen , Zhenyu Zhou , Dengxia Wang , Chuqiao Liu , Chunxiang Mo , Suqing Tian , Ying Wu , Jibin Song
Radiotherapy remains a cornerstone in oncology, yet its efficacy is limited by tumor radioresistance and off-target toxicity. This review elucidates the transformative potential of hafnium (Hf)-based radiosensitizers in overcoming these challenges. Leveraging Hf's high atomic number, these Hf-based biomaterials enhance X-ray energy deposition through photoelectric and Auger effects, generate cytotoxic reactive oxygen species (ROS), and modulate immunosuppressive tumor microenvironments to enhance radiotherapy effect. Their distinctive capability to achieve multimodal synergy by integrating radiotherapy with photodynamic, chemotherapeutic, or immunotherapeutic strategies enables precise targeting and significantly enhances antitumor responses. Subsequently, this review rigorously assessed the current synthetic methodologies for Hf-based radiosensitizers, along with their capacities and limitations in terms of controlling material properties and ensuring scalability. Advanced imaging modalities such as fluorescence, CT, SPECT, MRI, and PA further establish Hf-based systems as theranostic platforms for real-time tumor localization and treatment monitoring. While clinical candidates like NBTXR3 exhibit promising trial outcomes, challenges remain in mechanistic clarification, biocompatibility optimization, and controlled in vivo degradation. Emerging AI-driven design and multidisciplinary integration hold promise to expedite clinical translation, advancing Hf-based radiosensitizers toward intelligent, personalized cancer therapy paradigms. This work highlights Hf's critical role in redefining precision radiotherapy and delineates a roadmap for next-generation oncological intervention.
{"title":"Multimodal synergistic effects and theranostic integration of hafnium-based nanoradiosensitizers for enhancing precision radiotherapy","authors":"Yiwei Chen , Zhenyu Zhou , Dengxia Wang , Chuqiao Liu , Chunxiang Mo , Suqing Tian , Ying Wu , Jibin Song","doi":"10.1016/j.biomaterials.2025.123918","DOIUrl":"10.1016/j.biomaterials.2025.123918","url":null,"abstract":"<div><div>Radiotherapy remains a cornerstone in oncology, yet its efficacy is limited by tumor radioresistance and off-target toxicity. This review elucidates the transformative potential of hafnium (Hf)-based radiosensitizers in overcoming these challenges. Leveraging Hf's high atomic number, these Hf-based biomaterials enhance X-ray energy deposition through photoelectric and Auger effects, generate cytotoxic reactive oxygen species (ROS), and modulate immunosuppressive tumor microenvironments to enhance radiotherapy effect. Their distinctive capability to achieve multimodal synergy by integrating radiotherapy with photodynamic, chemotherapeutic, or immunotherapeutic strategies enables precise targeting and significantly enhances antitumor responses. Subsequently, this review rigorously assessed the current synthetic methodologies for Hf-based radiosensitizers, along with their capacities and limitations in terms of controlling material properties and ensuring scalability. Advanced imaging modalities such as fluorescence, CT, SPECT, MRI, and PA further establish Hf-based systems as theranostic platforms for real-time tumor localization and treatment monitoring. While clinical candidates like NBTXR3 exhibit promising trial outcomes, challenges remain in mechanistic clarification, biocompatibility optimization, and controlled in vivo degradation. Emerging AI-driven design and multidisciplinary integration hold promise to expedite clinical translation, advancing Hf-based radiosensitizers toward intelligent, personalized cancer therapy paradigms. This work highlights Hf's critical role in redefining precision radiotherapy and delineates a roadmap for next-generation oncological intervention.</div></div>","PeriodicalId":254,"journal":{"name":"Biomaterials","volume":"329 ","pages":"Article 123918"},"PeriodicalIF":12.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145792756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-06-01Epub Date: 2025-12-22DOI: 10.1016/j.biomaterials.2025.123940
Tianwu Chen , Shuang Wang , Wei Wu , Jiawei Liu , Peng Zhang , Xiaopei Wu , Honglian Dai
Polyethylene terephthalate (PET) artificial ligaments have been widely applied in anterior cruciate ligament (ACL) reconstruction due to their excellent mechanical properties. However, their biological inertness often results in poor graft-bone integration, potentially limiting long-term clinical outcomes. Recent studies have highlighted the temporally dynamic nature of the peri-implant microenvironment following implantation, where early-stage oxidative stress, inflammatory responses, and potential bacterial contamination disrupt the transition to vascularized bone regeneration. Therefore, the development of a spatiotemporally responsive interfacial system capable of adapting to this pathological-to-regenerative shift is essential for enhancing the biological performance of synthetic grafts. Here, we propose a bilayered functional coating strategy with phase-specific responsiveness and spatial complementarity. The outer layer comprises a hyaluronic acid-based hydrogel embedded with molybdenum disulfide (MoS2) nanosheets, enabling early-stage reactive oxygen species (ROS) scavenging and near-infrared (NIR)-activated photothermal antibacterial effects. The inner layer, composed of plasma-sprayed strontium-doped hydroxyapatite (Sr-HA), is activated under stabilized conditions to induce macrophage polarization toward the M2 phenotype and promote angiogenic osteogenesis. In a rat ACL reconstruction model, this bilayered coating significantly improved new bone formation and graft–bone integration. Collectively, this study presents a spatiotemporally programmable interfacial modulation strategy that aligns with the healing rhythm of ACL reconstruction, achieving a closed-loop regulation from early inflammation suppression to late-stage immuno-osteogenic regeneration. This approach offers a mechanistically grounded and translationally promising pathway for functionalizing synthetic ligament grafts.
{"title":"A spatiotemporally programmed bilayer coating for immunomodulatory and osteogenic enhancement of artificial ligament-bone integration","authors":"Tianwu Chen , Shuang Wang , Wei Wu , Jiawei Liu , Peng Zhang , Xiaopei Wu , Honglian Dai","doi":"10.1016/j.biomaterials.2025.123940","DOIUrl":"10.1016/j.biomaterials.2025.123940","url":null,"abstract":"<div><div>Polyethylene terephthalate (PET) artificial ligaments have been widely applied in anterior cruciate ligament (ACL) reconstruction due to their excellent mechanical properties. However, their biological inertness often results in poor graft-bone integration, potentially limiting long-term clinical outcomes. Recent studies have highlighted the temporally dynamic nature of the peri-implant microenvironment following implantation, where early-stage oxidative stress, inflammatory responses, and potential bacterial contamination disrupt the transition to vascularized bone regeneration. Therefore, the development of a spatiotemporally responsive interfacial system capable of adapting to this pathological-to-regenerative shift is essential for enhancing the biological performance of synthetic grafts. Here, we propose a bilayered functional coating strategy with phase-specific responsiveness and spatial complementarity. The outer layer comprises a hyaluronic acid-based hydrogel embedded with molybdenum disulfide (MoS<sub>2</sub>) nanosheets, enabling early-stage reactive oxygen species (ROS) scavenging and near-infrared (NIR)-activated photothermal antibacterial effects. The inner layer, composed of plasma-sprayed strontium-doped hydroxyapatite (Sr-HA), is activated under stabilized conditions to induce macrophage polarization toward the M2 phenotype and promote angiogenic osteogenesis. In a rat ACL reconstruction model, this bilayered coating significantly improved new bone formation and graft–bone integration. Collectively, this study presents a spatiotemporally programmable interfacial modulation strategy that aligns with the healing rhythm of ACL reconstruction, achieving a closed-loop regulation from early inflammation suppression to late-stage immuno-osteogenic regeneration. This approach offers a mechanistically grounded and translationally promising pathway for functionalizing synthetic ligament grafts.</div></div>","PeriodicalId":254,"journal":{"name":"Biomaterials","volume":"329 ","pages":"Article 123940"},"PeriodicalIF":12.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145881566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Impaired skin wound healing with excessive inflammation affects millions of patients globally. The resulting chronic pain can severely impact the quality of life for people afflicted by the condition. However, the treatment of skin wounds faces enormous challenges due to complex wound microenvironments. Here, we report the design of bioengineered hybrid nanovesicles (BHNVs) that enable advanced wound healing by concurrently providing effective intercellular junction and inflammation relief. The surface of hybrid nanovesicles is modified by trans-membrane DNA functional structures with a zipper part at the outside and a DNAzyme signal output part at the inside. Asiaticoside, an active ingredient from herbal medicines, and signal recognition DNA complex are encapsulated into the nanovesicles. From both outside and inside, these components of the hybrid nanovesicles work synergistically to address wound healing from both extra- and intracellular perspectives. Upon vesicle-cell fusion, the zipper part at the outside can facilitate cell-cell junction, and the DNAzyme signal output part at the inside can hinder while monitoring inflammatory responses. The released Asiaticoside can improve cell proliferation, enhance angiogenesis, accelerate cell migration/adhesion, and promote wound healing with the combination effect of anti-oxidation and anti-ulceration. Together, BHNVs are shown to successfully accelerate wound healing and prevent inflammation. Favorable therapeutic outcomes are achieved both in vitro and in vivo, indicating a robust modality for local wound management with enhanced therapeutic effects.
{"title":"Synergistic intercellular junction and anti-inflammation wound healing therapy via bioengineered hybrid nanovesicles","authors":"Shi-Yi Zhang , Zhi-Ying He , Ze-Rui Zhou , Han-Bin Xu , Shi-Yu Zheng , Xin-Yue Liu , Meng-Qi Zhao , Bin-Bin Chen , Da-Wei Li , Ruo-Can Qian , Jiang-Wei Tian","doi":"10.1016/j.biomaterials.2026.123999","DOIUrl":"10.1016/j.biomaterials.2026.123999","url":null,"abstract":"<div><div>Impaired skin wound healing with excessive inflammation affects millions of patients globally. The resulting chronic pain can severely impact the quality of life for people afflicted by the condition. However, the treatment of skin wounds faces enormous challenges due to complex wound microenvironments. Here, we report the design of bioengineered hybrid nanovesicles (BHNVs) that enable advanced wound healing by concurrently providing effective intercellular junction and inflammation relief. The surface of hybrid nanovesicles is modified by <em>trans</em>-membrane DNA functional structures with a zipper part at the outside and a DNAzyme signal output part at the inside. Asiaticoside, an active ingredient from herbal medicines, and signal recognition DNA complex are encapsulated into the nanovesicles. From both outside and inside, these components of the hybrid nanovesicles work synergistically to address wound healing from both extra- and intracellular perspectives. Upon vesicle-cell fusion, the zipper part at the outside can facilitate cell-cell junction, and the DNAzyme signal output part at the inside can hinder while monitoring inflammatory responses. The released Asiaticoside can improve cell proliferation, enhance angiogenesis, accelerate cell migration/adhesion, and promote wound healing with the combination effect of anti-oxidation and anti-ulceration. Together, BHNVs are shown to successfully accelerate wound healing and prevent inflammation. Favorable therapeutic outcomes are achieved both in vitro and in vivo, indicating a robust modality for local wound management with enhanced therapeutic effects.</div></div>","PeriodicalId":254,"journal":{"name":"Biomaterials","volume":"329 ","pages":"Article 123999"},"PeriodicalIF":12.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145973459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-06-01Epub Date: 2026-01-03DOI: 10.1016/j.biomaterials.2026.123980
Yu Wu , Wen Zhang , Linlin Huang , Xinping Xu , Yue Wang , Long Bai , Li Yang , Cheng Hu , Yunbing Wang
After myocardial infarction (MI), oxidative stress, inflammatory response and myocardial fibrosis severely impair tissue regeneration. Aiming at the problem that multifunctional hydrogel systems are difficult to achieve precise therapeutic regulation due to limited response characteristics and insufficient synergistic effect. Here, we developed an adaptive hydrogel platform for targeted nitric oxide (NO) release and post-infarction cardiac microenvironment modulation. A small molecule phenylboronic acid-based cross-linker (N(BA)4) with a four-arm topology was reported for the first time, and it was combined with Nitroso glutathione (GSNO)-modified polyvinyl alcohol (PVA) to prepare the hydrogel platform. For the multi-stage of myocardial repair, bioactive microspheres with programmed delivery function were prepared, which could rapidly release the salvianolic acid B in the pre-infarct stage to exert antioxidant and pro-angiogenic effects, and continuously release the fibrosis inhibitor Galunsertib in the post-infarct stage to inhibit fibrosis. The pathologically responsive composite hydrogel system enables precise and efficient MI therapy through a cascade-triggered drug release mechanism and multi-pathway synergy. It provides a novel and promising strategy to overcome the challenges of different pathological stages in the infarcted cardiac microenvironment.
{"title":"Adaptive hydrogel platform for nitric oxide release and post-infarction cardiac microenvironment modulation","authors":"Yu Wu , Wen Zhang , Linlin Huang , Xinping Xu , Yue Wang , Long Bai , Li Yang , Cheng Hu , Yunbing Wang","doi":"10.1016/j.biomaterials.2026.123980","DOIUrl":"10.1016/j.biomaterials.2026.123980","url":null,"abstract":"<div><div>After myocardial infarction (MI), oxidative stress, inflammatory response and myocardial fibrosis severely impair tissue regeneration. Aiming at the problem that multifunctional hydrogel systems are difficult to achieve precise therapeutic regulation due to limited response characteristics and insufficient synergistic effect. Here, we developed an adaptive hydrogel platform for targeted nitric oxide (NO) release and post-infarction cardiac microenvironment modulation. A small molecule phenylboronic acid-based cross-linker (N(BA)<sub>4</sub>) with a four-arm topology was reported for the first time, and it was combined with Nitroso glutathione (GSNO)-modified polyvinyl alcohol (PVA) to prepare the hydrogel platform. For the multi-stage of myocardial repair, bioactive microspheres with programmed delivery function were prepared, which could rapidly release the salvianolic acid B in the pre-infarct stage to exert antioxidant and pro-angiogenic effects, and continuously release the fibrosis inhibitor Galunsertib in the post-infarct stage to inhibit fibrosis. The pathologically responsive composite hydrogel system enables precise and efficient MI therapy through a cascade-triggered drug release mechanism and multi-pathway synergy. It provides a novel and promising strategy to overcome the challenges of different pathological stages in the infarcted cardiac microenvironment.</div></div>","PeriodicalId":254,"journal":{"name":"Biomaterials","volume":"329 ","pages":"Article 123980"},"PeriodicalIF":12.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145916325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-06-01Epub Date: 2025-12-31DOI: 10.1016/j.biomaterials.2025.123972
Yinqi Chen , Jiafeng Wang , Yechun Wang , Zimeng Liu , Jiajia Ying , Xuefei Zhou , Tianhua Zhou , Haiping Jiang , Xiangrui Liu , Quan Zhou
Postoperative adhesions are frequent and challenging complication lacking effective prevention. Evidence indicates that innate immune responses triggered by surgical trauma critically influence whether normal tissue repair progresses to pathological adhesions, highlighting early inflammatory responders as key intervention targets. Here, we successfully transformed natural hyaluronic acid (HA) into a potent innate inflammation modulator through a one-step sulfoxide-conjugation strategy. The resultant sulfoxide-conjugated HA (SOHA) demonstrated near-complete prevention of adhesion formation across multiple clinically relevant animal models, including those for secondary injury, long-term abdominal adhesions, and pericardial–pleural adhesions. Mechanistic investigations reveal that, unlike traditional physical barriers that primarily inhibit the late-stage adhesion of activated fibroblasts, SOHA addresses postoperative adhesions at their inception by reprogramming early innate inflammatory responses. It shifts the neutrophil cell death mode from acute, pro-inflammatory NETosis to more regulated, immunologically silent apoptotic process. Furthermore, it selectively restrains the early accumulation of large peritoneal macrophages (LPMs) in damaged tissues, redirecting them towards a reparative M2-like phenotype through the efferocytic clearance of apoptotic neutrophils, thereby promoting their timely involvement during the resolution phase of inflammation. This dual regulation of innate immunity effectively interrupts the postoperative inflammatory cascade and subsequent fibrotic progression, thus effectively shifting the pathological tissue repair into physiological healing.
{"title":"An innate immunity-reprogramming hydrogel nips postoperative adhesions in the bud via transforming pathological healing into physiological recovery","authors":"Yinqi Chen , Jiafeng Wang , Yechun Wang , Zimeng Liu , Jiajia Ying , Xuefei Zhou , Tianhua Zhou , Haiping Jiang , Xiangrui Liu , Quan Zhou","doi":"10.1016/j.biomaterials.2025.123972","DOIUrl":"10.1016/j.biomaterials.2025.123972","url":null,"abstract":"<div><div>Postoperative adhesions are frequent and challenging complication lacking effective prevention. Evidence indicates that innate immune responses triggered by surgical trauma critically influence whether normal tissue repair progresses to pathological adhesions, highlighting early inflammatory responders as key intervention targets. Here, we successfully transformed natural hyaluronic acid (HA) into a potent innate inflammation modulator through a one-step sulfoxide-conjugation strategy. The resultant sulfoxide-conjugated HA (SOHA) demonstrated near-complete prevention of adhesion formation across multiple clinically relevant animal models, including those for secondary injury, long-term abdominal adhesions, and pericardial–pleural adhesions. Mechanistic investigations reveal that, unlike traditional physical barriers that primarily inhibit the late-stage adhesion of activated fibroblasts, SOHA addresses postoperative adhesions at their inception by reprogramming early innate inflammatory responses. It shifts the neutrophil cell death mode from acute, pro-inflammatory NETosis to more regulated, immunologically silent apoptotic process. Furthermore, it selectively restrains the early accumulation of large peritoneal macrophages (LPMs) in damaged tissues, redirecting them towards a reparative M2-like phenotype through the efferocytic clearance of apoptotic neutrophils, thereby promoting their timely involvement during the resolution phase of inflammation. This dual regulation of innate immunity effectively interrupts the postoperative inflammatory cascade and subsequent fibrotic progression, thus effectively shifting the pathological tissue repair into physiological healing.</div></div>","PeriodicalId":254,"journal":{"name":"Biomaterials","volume":"329 ","pages":"Article 123972"},"PeriodicalIF":12.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145881568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}